Equity Research, Broker Reports, and media content on Allergy Therapeutics plc

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Allergy Therapeutics plc
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Allergy Therapeutics plc

Company Profile

  • Personnel
  • Manuel Llobet , CEO
  • Nicolas Wykeman, Finance Director

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Allergy Therapeutics plc. We currently have 264 research reports from 11 professional analysts.

  • Open: N/A
  • Range Today: N/A
  • 52 Week: 10.5/25.0p
  • Daily Volume: N/A
  • Daily Liquidity: (0.02%)
  • # Shares: 637.3m
  • Market Cap: £138.6m
  • Latest PE (hist): 23.36
  • Div Yield:
Date Source Announcement
06May21 07:00 RNS Completion of treatment phase in G309 study
30Apr21 17:47 RNS Total Voting Rights
16Apr21 07:00 RNS Appointment of new Group auditors
31Mar21 08:29 RNS Vesting of Awards under Long Term Incentive Plan
26Mar21 16:39 RNS Pledge of Shares
11Mar21 12:13 RNS Pledge of Shares
10Mar21 16:40 RNS Second Price Monitoring Extn
  • Frequency of research reports


  • Research reports on

    Allergy Therapeutics plc

  • Providers covering

    Allergy Therapeutics plc